We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.69%
AUM
$1.43B
AUM Growth
+$140M
Cap. Flow
+$62.6M
Cap. Flow %
4.36%
Top 10 Hldgs %
17.76%
Holding
218
New
47
Increased
72
Reduced
39
Closed
34

Top Buys

Rank Stock Value
1
DMTK
DermTech, Inc. Common Stock
DMTK
+$20.7M
2
TLIS
Talis Biomedical Corporation Common Stock
TLIS
+$18.3M
3
KALV
KalVista Pharmaceuticals
KALV
+$15.6M
4
TIL icon
Instil Bio
TIL
+$14.1M
5
XOM icon
ExxonMobil
XOM
+$13.2M

Top Sells

Rank Stock Value
1
TDOC icon
Teladoc Health
TDOC
+$25.2M
2
IOVA icon
Iovance Biotherapeutics
IOVA
+$23.6M
3
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$13.8M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$13.5M
5
CZR icon
Caesars Entertainment
CZR
+$10.5M

Sector Composition

Rank Sector Weight
1 Healthcare 47.74%
2 Technology 10.12%
3 Industrials 8.37%
4 Financials 7.73%
5 Consumer Discretionary 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TGTX icon
1
TG Therapeutics
TGTX
$7.07B
$30.2M 2.1%
625,787
-2,385
-0.4% -$115K
BBIO icon
2
BridgeBio Pharma
BBIO
$15.7B
$30.2M 2.1%
489,623
+77,852
+19% +$5.09M
RGEN icon
3
Repligen
RGEN
$8.3B
$27.6M 1.93%
142,103
+11,612
+9% +$2.38M
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$25.7M 1.79%
375,654
+105,292
+39% +$8.52M
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$24.9M 1.74%
270,631
-14,415
-5% -$1.22M
ARGX icon
6
argenx
ARGX
$52B
$23.7M 1.65%
86,128
+2,800
+3% +$885K
GH icon
7
Guardant Health
GH
$21.3B
$23.6M 1.64%
154,507
+2,459
+2% +$372K
KRYS icon
8
Krystal Biotech
KRYS
$9.21B
$23.5M 1.64%
304,689
+71,146
+30% +$5.17M
ARNA
9
DELISTED
Arena Pharmaceuticals Inc
ARNA
$22.8M 1.59%
327,942
+51,309
+19% +$3.95M
NEO icon
10
NeoGenomics
NEO
$2.04B
$22.7M 1.58%
470,452
+49,645
+12% +$2.58M
EXAS
11
DELISTED
Exact Sciences
EXAS
$22.2M 1.55%
168,284
+16,538
+11% +$2.26M
NVCR icon
12
NovoCure
NVCR
$1.78B
$21.3M 1.48%
161,137
+25,801
+19% +$4.08M
INSP icon
13
Inspire Medical Systems
INSP
$1.5B
$20.9M 1.46%
101,046
-4,049
-4% -$860K
TPTX
14
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$20.7M 1.44%
218,847
+35,171
+19% +$4.18M
KRNT icon
15
Kornit Digital
KRNT
$734M
$20.4M 1.42%
205,813
-50,521
-20% -$5M
OSH
16
DELISTED
Oak Street Health, Inc.
OSH
$20.2M 1.41%
372,841
+69,434
+23% +$3.86M
TWST icon
17
Twist Bioscience
TWST
$6.29B
$20.2M 1.4%
162,735
-16,140
-9% -$2.45M
DMTK
18
DELISTED
DermTech, Inc. Common Stock
DMTK
$20.1M 1.4%
+396,506
New +$20.7M
DCPH
19
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$20M 1.4%
446,674
+185,876
+71% +$8.65M
SDGR icon
20
Schrodinger
SDGR
$1.14B
$20M 1.39%
261,662
+12,856
+5% +$1.16M
AVTR icon
21
Avantor
AVTR
$9.25B
$19.7M 1.37%
680,900
+101,863
+18% +$2.94M
MPWR icon
22
Monolithic Power Systems
MPWR
$66B
$19.3M 1.34%
54,589
-937
-2% -$341K
GS icon
23
Goldman Sachs
GS
$303B
$19M 1.32%
57,961
+27,961
+93% +$8.71M
ITCI
24
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$18.8M 1.31%
554,545
+164,256
+42% +$5.7M
ZLAB icon
25
Zai Lab
ZLAB
$2.05B
$18.4M 1.29%
138,222
+49,351
+56% +$7.64M
1
2 3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Nicholas Investment Partners held 218 positions worth $1.43B, up 11% from $1.29B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners deployed $62.6M of net new capital in Q1 2021, opening 47 new positions and adding to 72 existing holdings. Its largest new stake was DermTech, Inc. Common Stock: 396,506 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 48% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Caesars Entertainment, an estimated $10.5M trimmed.

  • Nicholas Investment Partners's largest Q1 2021 buy was DermTech, Inc. Common Stock: 396,506 shares worth $20.1M.
  • Nicholas Investment Partners added most to 908 Devices in Q1 2021, an estimated $12.3M increase.
  • Nicholas Investment Partners's biggest Q1 2021 reduction was Caesars Entertainment, cutting an estimated $10.5M.
  • Nicholas Investment Partners fully exited Teladoc Health in Q1 2021, selling an estimated $25.2M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $1.43B portfolio in Q1 2021.
  • Nicholas Investment Partners opened 47 new positions and closed 34 in Q1 2021.
  • Nicholas Investment Partners's portfolio value rose 11% quarter-over-quarter to $1.43B.

Based on Nicholas Investment Partners's 13F filing for Q1 2021, filed 14 May 2021.